HOT NEWS
European Commission Issues Positive Decision for Approval of Seroquel XR » AstraZeneca announced that the European Commission (EC) has issued a positive decision for the appro...
Data from Mipomersen Phase 3 Trial in heFH Patients Presented at ESC » Genzyme Corp. (NASDAQ: GENZ) and Isis Pharmaceuticals Inc. (NASDAQ: ISIS) announced that data from t...
Global market launch of Daxas® (Roflumilast) kicks off in Germany » Stefan Brinkmann, Managing Director of Nycomed GmbH, kicked off the German market launch of Daxas® ...
A new era for patients with atrial fibrillation - Dabigatran etexilate at the fo... » The European Society of Cardiology (ESC) issued revised practice guidelines for the management of at...
Genetic substudy shows fewer major cardiovascular events with ticagrelor (BRILIN... » A new genetic substudy of PLATO (A Study of PLATelet Inhibition and Patient Outcomes) showed that th...
Shire Announces European Approval of VPRIV® (velaglucerase alfa) » Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced today...
Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet Need in Patients with Atrial ... » Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer (NYSE: PFE) report that preliminary results from...
GSK European Commission amends licence for Cervarix® » GlaxoSmithKline (GSK) confirmed that the European Commission has granted Marketing Authorisation to ...
Amgen Announces Top-Line Results of Phase 3 Head and Neck Cancer Trial » Amgen (Nasdaq: AMGN) announced top-line results from a randomized Phase 3 trial evaluating Vectibix(...
Pfizer Reports Second-Quarter 2010 Results » Pfizer Inc. (NYSE: PFE) has reported financial results for second-quarter 2010. Since the acquisitio...
Amgen
AmgenAmgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. For more information, please visit http://www.amgen.com

Amgen RSS Channel
Title Filter     Display # 
# Article Title Hits
1 Amgen Announces Top-Line Results of Phase 3 Head and Neck Cancer Trial 1190
2 Prolia(R) (Denosumab) Granted Marketing Authorization in the European Union 1390
3 Amgen Receives CHMP Positive Opinion for Prolia(TM) (Denosumab) in the European Union 1405
4 Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 1296
 
Bookmark and Share